Northwest Biotherapeutics (NWBO) EBITDA Margin (2010 - 2026)
Northwest Biotherapeutics' EBITDA Margin came in at -1342.13% for Q2 2026, up 9595.27 percentage points from -10937.40% a year earlier and up 708.27 percentage points from the prior quarter.
Northwest Biotherapeutics (NWBO) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Northwest Biotherapeutics reported EBITDA Margin of -2190.75%, up 3624.88 percentage points year-over-year; for FY2025, it was -4198.11%, up 488.14 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +2503.51 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -4686.25% in FY2024 (-1892.10 pp), -2794.15% in FY2023 (+1123.20 pp), -3917.35% in FY2022 (+1294.39 pp) and -5211.74% in FY2021 (+1489.89 pp).
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q4 2019.
- Year-over-year, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +389.26 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2021 (a gain of 19313.41 percentage points), and the weakest in Q2 2025 (a drop of 7598.19 percentage points).
- Business Quant data shows NWBO's EBITDA Margin at -2050.40% (Q1 2026), -1901.19% (Q4 2025) and -6934.50% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - | -1,342.13% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,342.13% |
| Mar 31, 2026 | -2,050.40% |
| Dec 31, 2025 | -1,901.19% |
| Sep 30, 2025 | -6,934.50% |
| Jun 30, 2025 | -10,937.40% |
| Mar 31, 2025 | -4,500.53% |
| Dec 31, 2024 | -7,819.05% |
| Sep 30, 2024 | -4,021.29% |
| Jun 30, 2024 | -3,339.22% |
| Mar 31, 2024 | -5,392.96% |
| Dec 31, 2023 | -3,307.42% |
| Sep 30, 2023 | -3,302.71% |
| Jun 30, 2023 | -6,580.60% |
| Mar 31, 2023 | -1,435.11% |
| Dec 31, 2022 | -2,991.62% |
| Sep 30, 2022 | -7,431.07% |
| Jun 30, 2022 | -4,313.42% |
| Mar 31, 2022 | -3,023.82% |
| Sep 30, 2021 | -2,844.00% |
| Jun 30, 2021 | -2,963.94% |
Northwest Biotherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();